A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)? - Anna Rose Childress; Ph.D. (ClinicalTrials.gov, 2025)